To the content
1 . 2021

Continuous flash glycemic monitoring in optimizing insulin pump therapy in a patient with type 1 diabetes mellitus: clinical case

Abstract

Many patients with type 1 diabetes mellitus (T1DM) undergoing pump insulin therapy have insufficient glycemic control and, as a result, inappropriate indicators of carbohydrate metabolism.

This clinical case shows us the clinical experience of pump insulin therapy optimization in a patient with T1DM based on continuous flash glucose monitoring (FGM) data.

The 35-year-old man with T1DM (diabetes duration - 21 years) undergoing insulin pump therapy with insufficient glycemia self-control (1-2 times a day) and an initial HbA1c level - 8% was installed the continuous flash glucose monitoring system (FGM) (1-14 days of the study) followed by a retrospective therapy correction according to the ambulatory glucose profile (14th day of the study), followed by control FGM using (14-28 days of the study).

This patient achieved the target values of carbohydrate metabolism, thanks to the combination of insulin pump therapy, which provides the possibility of highly personalization of insulin therapy and continuous flash glycemic monitoring, which allows optimizing blood glucose control.

As part of the follow-up, the patient showed a positive trend in the control of T1DM. There was a decrease in the average level of glycemia by 3.9 mmol/l and the calculated HbA1c by 1.9%.This clinical case shows that a visual representation of the continuous glycemia behavior allows patients to quickly master the principles of hypoglycemic therapy individualization and almost within a few days to receive such a quality of individualized hypoglycemic therapy which has never been achieved for years before.

Keywords:type 1 diabetes mellitus, pump insulin therapy, continuous flash-glucose monitoring systems

Funding. The study had no sponsor support.

Conflict of interests. The authors declare no conflict of interests.

For citation: Barsukov I.A., Dreval A.V., Slesareva E.A. Continuous flash glycemic monitoring in optimizing insulin pump therapy in a patient with type 1 diabetes mellitus: clinical case. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2021; 10 (1): 70-7. DOI: https://doi.org/10.33029/2304-9529-2021-10-1-70-77

References

1. Barsukov I.A., Demina A.A. New technologies in diabetes mellitus management: from theory to practice. Consilium Medicum. 2018; 20 (4): 24-8. DOI: https://doi.org/10.26442/2075-1753_2018.4.24-28 (in Russian)

2. Dreval’ A.V. Insulin pump therapy and continuous glycemic monitoring (clinical practice and prospects). Moscow: GEOTAR-Media, 2020: 336 p. (in Russian)

3. Battellino T., et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012; 55: 3155-62.

4. Dreval’ A.V. Diabetes practice. Moscow: GEOTAR-Media, 2018: 544 p. (in Russian)

5. Grose D.N., et al. Living with type 1 diabetes and an insulin pump: a qualitative insight. Pract Diabetes. 2018; 35 (5): 171-7.

6. Hussain S., Oliver N. Insulin Pumps and Continuous Glucose Monitoring Made Easy. 1st ed. Elsevier, 2016.

7. Choudhary P, et al. Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care. 2015; 38 (6): 1016-29.

8. Ehrmann D., et al. Efficacy of an education program for people with diabetes and insulin pump treatment (INPUT): results from a randomized controlled trial. Diabetes Care. 2018; 41 (12): 2453-62.

9. Choudhary P, et al. Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management. Diabetes Technol Ther. 2016; 18: 288-91.

10. Groat D., Grando M.A., Soni H., et al. Self-management behaviors in adults on insulin pump therapy. What are patients really doing? J Diabetes Sci Technol. 2017; 11: 233-9.

11. Levitt D.L., et al. Insulin pump and continuous glucose monitor initiation in hospitalized patients with type 2 diabetes mellitus. Diabetes Technol Ther. 2018; 20: 32-8.

12. Lopez P.E., Smart C.E., McElduff P, et al. Optimizing the combination insulin bolus split for a high-fat, high-protein meal in children and adolescents using insulin pump therapy. Diabet Med. 2017; 34: 1380-4.

13. Scheiner G., Sobel R.J., Smith D.E., Pick A.J., et al. Insulin pump therapy: guidelines for successful outcomes. Diabetes Educ. 2009; 35 (suppl 2): 29S-41S.

14. McAuley S.A., Ward G.M., Horsburgh J.C., et al. Asymmetric changes in circulating insulin levels after an increase compared with a reduction in insulin pump basal rate in people with type 1 diabetes. Diabet Med. 2017; 34: 1158-64.

15. Nimri R., et al. Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: variations among countries and physicians. Diabetes Obes Metab. 2018; 20 (10): 2458-66.

16. Beck R.W., et al. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. Lancet. 2017; 5 (9): 700-8.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»